Company: ADPT
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030913
Chunk: 204

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 204
---
b5-1 trading plan. Ms. Griffin’s plan provides for the sale of up to 50% of the net vested shares of our common stock received in connection with the vesting of certain restricted stock units. The plan's expiration date is March 14, 2025. This plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and our policies regarding transactions in our securities.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

123

PART III 

Item 10. Directors, Executive Officers and Corporate Governance 

The information required by this Item 10 of the Annual Report on Form 10-K will be included in our definitive proxy statement to be filed with the SEC in connection with the solicitation of proxies for our 2025 Annual Meeting of Shareholders (“2025 Proxy Statement”) and is incorporated herein by reference.

Item 11. Executive Compensation 

The information required by this Item 11 of the Annual Report on Form 10-K will be included in our 2025 Proxy Statement and is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 

The information required by this Item 12 of the Annual Report on Form 10-K, including with respect to our equity compensation plans, will be included in our 2025 Proxy Statement and is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence 

The information required by this Item 13 of the Annual Report on Form 10-K will be included in our 2025 Proxy Statement and is incorporated herein by reference.

Item 14. Principal Accounting Fees and Services 

The information required by this Item 14 of the Annual Report on Form 10-K will be included in our 2025 Proxy Statement and is incorporated herein by reference.

124

PART IV 

Item 15. Exhibits, Financial Statement Schedules 

(a)  The following documents are filed as part of this Annual Report on Form 10-K:

(1)   Financial Statements

See Index to Consolidated Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K.

(2)   Financial Statement Schedules

All financial statement schedules have been omitted since the required information was not applicable or was not present in amounts sufficient to require submission of the schedules, or because the information required is included in the consolidated financial statements or